Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 29 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FIRST ALBANY COMPANIES INC | 35,568,261 | reported | 27 Aug 2009 | tx 2−7,525,000 |
| STANDARD PACIFIC CORP /DE/ | 28,332,549 | reported | 14 Jun 2017 | tx 6+60,069,579−37,960,837 |
| TOREADOR RESOURCES CORP | 2,201,477 | reported | 01 Oct 2009 | tx 183+78,463−27,600 |
| Atlas Therapeutics Corp | 1,267,477 | reported | 06 Mar 2020 | tx 1+206,611 |
| Matlin & Partners Acquisition Corp | 697,674 | reported | 02 Mar 2022 | tx 12+16,602,403−1,348,729 |
| TriSalus Life Sciences, Inc. | 121,403 | reported | 14 May 2026 | tx 12+2,544,632−75,000 |
| FLAGSTAR BANCORP INC | 2,867 | reported | 20 Jan 2021 | tx 23+1,204,252,605−44,784,989 |
| Clene Inc. | 1,500 | reported | 21 May 2026 | tx 68+9,849,429−62,500 |
| Huntsman CORP | 0 | reported | 07 Oct 2009 | tx 4−62,432,005 |
| Lonestar Resources US Inc. | 0 | reported | 05 Oct 2021 | tx 1−1,909,786 |
4 purchases reported after at least 12 months of silence — most recent on 13 Jan 2026.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Clene Inc. | 1,500 | 0.00 USD | deriv |
| 21 May 2026 | GRANT_AWARD | Clene Inc. | 3,659 | 0.00 USD | deriv |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 28,201 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 23,065 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 56,403 | 0.00 USD | deriv |
| 19 Feb 2026 | GRANT_AWARD | Clene Inc. | 5,372 | 0.00 USD | deriv |
| 13 Jan 2026 | PURCHASE | Clene Inc. | 33,333 | 6.50 USD | first after silence |
| 13 Jan 2026 | GRANT_AWARD | Clene Inc. | 93,333 | — | deriv |
| 13 Jan 2026 | GRANT_AWARD | Clene Inc. | 40,000 | — | deriv |
| 13 Nov 2025 | GRANT_AWARD | Clene Inc. | 3,692 | 0.00 USD | deriv |
| 14 Aug 2025 | GRANT_AWARD | Clene Inc. | 7,255 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Clene Inc. | 1,500 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Clene Inc. | 10,209 | 0.00 USD | deriv |
| 27 Feb 2025 | GRANT_AWARD | Clene Inc. | 5,628 | 0.00 USD | deriv |
| 10 Feb 2025 | OTHER | TriSalus Life Sciences, Inc. | 89,501 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 10,040 | 0.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | Clene Inc. | 5,563 | 0.00 USD | deriv |
| 02 Oct 2024 | GRANT_AWARD | Clene Inc. | 4,990 | 0.00 USD | deriv |
| 30 Sept 2024 | PURCHASE | Clene Inc. | 92,307 | 4.75 USD | |
| 30 Sept 2024 | GRANT_AWARD | Clene Inc. | 92,307 | 0.13 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | TriSalus Life Sciences, Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Clene Inc. | 65,723 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Clene Inc. | 30,000 | 0.00 USD | deriv |
| 11 Mar 2024 | GRANT_AWARD | Clene Inc. | 57,488 | 0.00 USD | deriv |